Hepato‐Cardiac Axis in Epirubicin Toxicity: Role of Kynurenine Pathway and N‐Acetylcysteine Antioxidant Intervention
- 20 February 2026
- journal article
- Published by Wiley in Journal of Applied Toxicology
- Vol. 46 (9) , 3244-3256
Abstract
Epirubicin (EPI) is a widely used chemotherapeutic agent; however, its clinical utility is limited by severe side effects, particularly the production of reactive oxygen species (ROS). Among these, cardiotoxicity is one of the most critical issues, and it is worsened by impaired hepatic clearance resulting from liver dysfunction. This study aimed to investigate molecular changes induced by EPI in the liver within the kynurenine pathway (KP), their possible contribution to cardiotoxicity, and the protective effects of N‐acetylcysteine (NAC). Rats received intraperitoneal injections of 50 or 300 mg/kg NAC, followed 1 h later by 9.6 mg/kg EPI. Tryptophan (Trp), kynurenine (Kyn), kynurenic acid (KYNA), quinolinic acid (QA), kynureninase, and kynurenine 3‐monooxygenase (KMO) levels in the liver and cleaved caspase‐3 levels in the liver and heart tissue were measured using ELISA. Hepatic and cardiac total antioxidant status (TAS) and total oxidant status (TOS) were determined using a colorimetric method. Plasma levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), creatine kinase (CK), creatine kinase–MB isoenzyme (CK‐MB), high‐density lipoprotein (HDL), low‐density lipoprotein (LDL), total cholesterol (T‐chol), and triglyceride (TG) were analyzed with a clinical biochemistry analyzer. Cardiac morphology was examined using hematoxylin–eosin staining. EPI administration was associated with increases in plasma CK‐MB, the AST/ALT ratio, LDL, T‐chol, and TG, with these increases partially attenuated by NAC treatment. Hepatic levels of Trp, QA, and KMO were positively correlated with plasma CK‐MB and the AST/ALT ratio. Additionally, EPI appeared to increase oxidative stress in heart tissue and induce morphological changes. At the same time, NAC treatment was associated with partial improvement in these parameters, suggesting that alterations in the hepatic KP may be linked to possible cardiac involvement. Our findings suggest that EPI‐induced alterations in hepatic KP may impair hepatic clearance, and NAC administration may provide partial protection, warranting further investigation of a possible hepato‐cardiac interaction.Keywords
This publication has 54 references indexed in Scilit:
- Effects of Doxorubicin, Epirubicin, and Liposomal Doxorubicin (Anthracycline) on cardiac function in patients with osteosarcoma and their influencing factorsClinical and Translational Oncology, 2024
- A single chemotherapy administration induces muscle atrophy, mitochondrial alterations and apoptosis in breast cancer patientsJournal of Cachexia, Sarcopenia and Muscle, 2024
- Cardiovascular status of breast cancer patients before and after receiving anthracycline chemotherapy regimenNursing Open, 2021
- Oxidative stress and inflammation: determinants of anthracycline cardiotoxicity and possible therapeutic targetsHeart Failure Reviews, 2020
- Consensus Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Adults with Chronic Viral Hepatitis and Adults with Cirrhosis Secondary to Hepatitis B, C and Nonalcoholic SteatohepatitisDrug Safety, 2020
- Sarcopenia as a risk factor of severe laboratory adverse events in breast cancer patients receiving perioperative epirubicin plus cyclophosphamide therapySupportive Care in Cancer, 2020
- Biomarkers distinguish apoptotic and necrotic cell death during hepatic ischemia/reperfusion injury in miceLiver Transplantation, 2014
- A Comparison of Apoptosis and Necrosis Induced by Hepatotoxins in HepG2 CellsToxicology and Applied Pharmacology, 2000
- Epirubicin in hepatocellular carcinoma: pharmacokinetics and clinical activityCancer Chemotherapy and Pharmacology, 1994
- Effect of Dichloroacetate on Plasma and Hepatic Amino Acids in Sterile Inflammation and SepsisArchives of Surgery, 1989